The New York Times did a hatchet job on regenerative medicine. A visiting researcher at New York-Presbyterian/Weill Cornell Medical Center and other surgeons had performed numerous surgeries using BioBurst, a processed umbilical cord fluid, to help fuse together bones in minimally invasive surgeries. The fluid was administered to reduce healing time and reduce the need for more invasive back surgery.
Category: Cost of Healthcare
Monday Links
- Health gains from key prescription drugs.
- Steve Henke, et. al., skewer a new Royal Society report on Covid-19.
- Health Affairs study: employers lack leverage to negotiate lower prices. Have they never heard of reference pricing?
- CDC: we are losing the battle against obesity. I thought we lost it a long time ago.
- Inequities at the doctors office: is it because the patients don’t speak up for themselves?
Saturday Links
- Patience is correlated with more success in school.
- “Aspirations cannot become law.” Sen. Bill Cassidy on Bernie Sanders’ latest health care proposal.
- Peter Nelson: How to make price transparency better.
- Is a female takeover of elite occupations taking place?
- Penn Wharton model: The federal government’s unfunded liability is $244.8 billion.
Hospital Online Price Estimators Don’t Match Phone Quotes
Hospitals make it notoriously difficult to know the price prior to a service. Prices are hard to obtain and often meaningless when disclosed. Indeed, there isn’t one price but many prices depending upon who the payer is. There is a different price for BlueCross, Aetna, Cigna and most other health plans. There is the chargemaster…